Jeffrey Schowinsky
Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myeloid, Acute | 9 | 2026 | 702 | 0.930 |
Why?
| | Mycosis Fungoides | 2 | 2018 | 63 | 0.580 |
Why?
| | Azacitidine | 5 | 2026 | 168 | 0.570 |
Why?
| | Brain Neoplasms | 3 | 2018 | 1325 | 0.520 |
Why?
| | Lipomatosis | 1 | 2015 | 4 | 0.440 |
Why?
| | HMGA2 Protein | 1 | 2015 | 10 | 0.440 |
Why?
| | Adamantinoma | 1 | 2015 | 4 | 0.440 |
Why?
| | Synovial Membrane | 1 | 2015 | 130 | 0.400 |
Why?
| | Keratins | 3 | 2026 | 57 | 0.390 |
Why?
| | Tibia | 1 | 2015 | 177 | 0.380 |
Why?
| | Eosinophilia | 1 | 2015 | 224 | 0.380 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 7 | 2026 | 1998 | 0.370 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2017 | 992 | 0.370 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 7 | 2026 | 292 | 0.360 |
Why?
| | Lymphoma, T-Cell, Peripheral | 1 | 2012 | 19 | 0.350 |
Why?
| | Skin Neoplasms | 2 | 2018 | 806 | 0.350 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2012 | 66 | 0.330 |
Why?
| | Sulfonamides | 7 | 2026 | 594 | 0.320 |
Why?
| | Soft Tissue Neoplasms | 2 | 2023 | 133 | 0.270 |
Why?
| | Dendritic Cell Sarcoma, Follicular | 1 | 2026 | 4 | 0.230 |
Why?
| | Epithelioid Cells | 1 | 2026 | 9 | 0.230 |
Why?
| | Biopsy, Needle | 1 | 2006 | 183 | 0.230 |
Why?
| | Clonal Evolution | 2 | 2017 | 47 | 0.230 |
Why?
| | Pleural Neoplasms | 1 | 2026 | 31 | 0.230 |
Why?
| | Rectum | 1 | 2006 | 180 | 0.210 |
Why?
| | Diagnostic Errors | 1 | 2006 | 178 | 0.210 |
Why?
| | Tissue Scaffolds | 1 | 2024 | 223 | 0.180 |
Why?
| | Carrier Proteins | 2 | 2017 | 728 | 0.180 |
Why?
| | Nuclear Proteins | 2 | 2017 | 740 | 0.170 |
Why?
| | Mastocytosis, Cutaneous | 1 | 2021 | 6 | 0.160 |
Why?
| | Surgical Wound Infection | 1 | 2024 | 349 | 0.160 |
Why?
| | Mastocytosis | 1 | 2021 | 15 | 0.160 |
Why?
| | Extracellular Matrix | 1 | 2024 | 565 | 0.160 |
Why?
| | Biomarkers, Tumor | 3 | 2026 | 1339 | 0.150 |
Why?
| | Adenocarcinoma | 1 | 2006 | 927 | 0.140 |
Why?
| | Prostatic Neoplasms | 1 | 2006 | 972 | 0.140 |
Why?
| | Fatal Outcome | 2 | 2018 | 302 | 0.140 |
Why?
| | Humans | 29 | 2026 | 146342 | 0.140 |
Why?
| | Tetrahydronaphthalenes | 1 | 2017 | 34 | 0.130 |
Why?
| | Leukemia, Neutrophilic, Chronic | 1 | 2017 | 5 | 0.130 |
Why?
| | Receptors, Colony-Stimulating Factor | 1 | 2017 | 7 | 0.130 |
Why?
| | Valine | 1 | 2017 | 84 | 0.130 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2017 | 80 | 0.120 |
Why?
| | Immunohistochemistry | 2 | 2026 | 1712 | 0.120 |
Why?
| | Pyrazoles | 2 | 2021 | 517 | 0.120 |
Why?
| | Mediastinal Neoplasms | 1 | 2017 | 54 | 0.120 |
Why?
| | Genetic Association Studies | 1 | 2018 | 379 | 0.120 |
Why?
| | Giant Cell Tumor of Bone | 1 | 2016 | 8 | 0.120 |
Why?
| | Skull Base Neoplasms | 1 | 2016 | 30 | 0.120 |
Why?
| | Middle Aged | 10 | 2026 | 36619 | 0.120 |
Why?
| | Mutation | 3 | 2017 | 4093 | 0.120 |
Why?
| | Neoplasms, Plasma Cell | 1 | 2015 | 5 | 0.120 |
Why?
| | Leukocytosis | 1 | 2015 | 31 | 0.110 |
Why?
| | Gene Frequency | 1 | 2017 | 496 | 0.110 |
Why?
| | Lymphoma | 1 | 2017 | 251 | 0.110 |
Why?
| | Neoplasm, Residual | 3 | 2023 | 143 | 0.110 |
Why?
| | Natalizumab | 2 | 2012 | 30 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 4 | 2016 | 3926 | 0.110 |
Why?
| | Tenosynovitis | 1 | 2015 | 11 | 0.110 |
Why?
| | Lipoma | 1 | 2015 | 17 | 0.110 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2017 | 268 | 0.110 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 299 | 0.110 |
Why?
| | Male | 15 | 2026 | 73396 | 0.100 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2020 | 893 | 0.100 |
Why?
| | Diagnosis, Differential | 3 | 2026 | 1503 | 0.100 |
Why?
| | Tissue Culture Techniques | 1 | 2013 | 82 | 0.100 |
Why?
| | Female | 15 | 2026 | 79499 | 0.090 |
Why?
| | Genomic Instability | 1 | 2013 | 64 | 0.090 |
Why?
| | Induction Chemotherapy | 2 | 2024 | 87 | 0.090 |
Why?
| | Immune Reconstitution Inflammatory Syndrome | 1 | 2012 | 19 | 0.090 |
Why?
| | Leukoencephalopathy, Progressive Multifocal | 1 | 2012 | 37 | 0.090 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 495 | 0.090 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2018 | 314 | 0.090 |
Why?
| | Ki-67 Antigen | 1 | 2012 | 120 | 0.090 |
Why?
| | CD3 Complex | 1 | 2012 | 113 | 0.090 |
Why?
| | Prognosis | 4 | 2024 | 4351 | 0.080 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2015 | 339 | 0.080 |
Why?
| | Leukocyte Count | 2 | 2024 | 321 | 0.080 |
Why?
| | Immunologic Factors | 1 | 2012 | 244 | 0.080 |
Why?
| | Antibodies, Monoclonal | 1 | 2017 | 1512 | 0.080 |
Why?
| | Neutrophils | 1 | 2015 | 1133 | 0.080 |
Why?
| | Adult | 9 | 2026 | 41087 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2488 | 0.070 |
Why?
| | Treatment Outcome | 5 | 2026 | 11821 | 0.070 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2016 | 1160 | 0.070 |
Why?
| | Antineoplastic Agents | 2 | 2017 | 2219 | 0.070 |
Why?
| | Lymphatic Diseases | 1 | 2008 | 21 | 0.070 |
Why?
| | Membrane Proteins | 1 | 2015 | 1130 | 0.070 |
Why?
| | Bone Marrow | 3 | 2017 | 310 | 0.070 |
Why?
| | Neutropenia | 1 | 2008 | 153 | 0.060 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2007 | 57 | 0.060 |
Why?
| | Racemases and Epimerases | 1 | 2006 | 11 | 0.060 |
Why?
| | Chromosome Aberrations | 2 | 2018 | 167 | 0.060 |
Why?
| | Pleura | 1 | 2026 | 28 | 0.060 |
Why?
| | Mucins | 1 | 2006 | 75 | 0.060 |
Why?
| | Retrospective Studies | 5 | 2024 | 17438 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 2 | 2016 | 2786 | 0.060 |
Why?
| | Prostate-Specific Antigen | 1 | 2006 | 162 | 0.060 |
Why?
| | Aged | 6 | 2024 | 26432 | 0.060 |
Why?
| | Carcinoma, Renal Cell | 1 | 2007 | 231 | 0.050 |
Why?
| | Hyphae | 1 | 2024 | 11 | 0.050 |
Why?
| | Young Adult | 4 | 2026 | 14330 | 0.050 |
Why?
| | Fungi | 1 | 2024 | 120 | 0.050 |
Why?
| | Biopsy | 2 | 2018 | 1075 | 0.050 |
Why?
| | Antigens, CD34 | 1 | 2023 | 89 | 0.050 |
Why?
| | Cytodiagnosis | 1 | 2023 | 31 | 0.050 |
Why?
| | Biopsy, Fine-Needle | 1 | 2023 | 79 | 0.050 |
Why?
| | Kidney Neoplasms | 1 | 2007 | 419 | 0.050 |
Why?
| | World Health Organization | 1 | 2023 | 104 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2021 | 8391 | 0.050 |
Why?
| | Disease Progression | 2 | 2023 | 2867 | 0.050 |
Why?
| | Wound Healing | 1 | 2024 | 354 | 0.040 |
Why?
| | Liver Neoplasms | 1 | 2007 | 776 | 0.040 |
Why?
| | Triazines | 1 | 2021 | 48 | 0.040 |
Why?
| | Intestinal Mucosa | 1 | 2006 | 666 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2018 | 1163 | 0.040 |
Why?
| | Pyrroles | 1 | 2021 | 222 | 0.040 |
Why?
| | Neoplastic Stem Cells | 1 | 2023 | 403 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2019 | 5439 | 0.040 |
Why?
| | Remission Induction | 1 | 2019 | 308 | 0.040 |
Why?
| | Karyotyping | 1 | 2018 | 106 | 0.030 |
Why?
| | Histocytochemistry | 1 | 2018 | 77 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2024 | 704 | 0.030 |
Why?
| | Temporomandibular Joint | 1 | 2016 | 8 | 0.030 |
Why?
| | Occipital Bone | 1 | 2016 | 18 | 0.030 |
Why?
| | Genetic Testing | 1 | 2019 | 492 | 0.030 |
Why?
| | Sphenoid Bone | 1 | 2016 | 15 | 0.030 |
Why?
| | Frontal Bone | 1 | 2016 | 19 | 0.030 |
Why?
| | Cranial Fossa, Middle | 1 | 2016 | 17 | 0.030 |
Why?
| | Temporal Bone | 1 | 2016 | 43 | 0.030 |
Why?
| | Nitriles | 1 | 2017 | 212 | 0.030 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2016 | 222 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2017 | 343 | 0.030 |
Why?
| | Administration, Oral | 1 | 2017 | 872 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2015 | 410 | 0.030 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2015 | 334 | 0.030 |
Why?
| | Recurrence | 1 | 2017 | 1133 | 0.030 |
Why?
| | Karyotype | 1 | 2013 | 18 | 0.020 |
Why?
| | Odds Ratio | 1 | 2016 | 1077 | 0.020 |
Why?
| | Pyrimidines | 1 | 2017 | 532 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 2013 | 238 | 0.020 |
Why?
| | Heterografts | 1 | 2013 | 143 | 0.020 |
Why?
| | Chondrogenesis | 1 | 2013 | 90 | 0.020 |
Why?
| | Bone Marrow Cells | 1 | 2013 | 328 | 0.020 |
Why?
| | Mice, Nude | 1 | 2013 | 668 | 0.020 |
Why?
| | Carcinogenesis | 1 | 2013 | 226 | 0.020 |
Why?
| | Protein Kinase Inhibitors | 1 | 2017 | 983 | 0.020 |
Why?
| | Infant | 2 | 2018 | 10114 | 0.020 |
Why?
| | Genetic Variation | 1 | 2013 | 996 | 0.020 |
Why?
| | Leukocyte Elastase | 1 | 2008 | 75 | 0.020 |
Why?
| | Cytokines | 1 | 2015 | 2081 | 0.020 |
Why?
| | Multiple Sclerosis | 1 | 2012 | 435 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 7109 | 0.010 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2012 | 931 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2013 | 2502 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2013 | 1982 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 3545 | 0.010 |
Why?
| | Brain | 1 | 2012 | 2991 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 22557 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2008 | 6460 | 0.010 |
Why?
| | Mice | 1 | 2013 | 18297 | 0.010 |
Why?
| | Animals | 1 | 2013 | 38107 | 0.010 |
Why?
| | Child | 1 | 2008 | 22693 | 0.000 |
Why?
|
|
Schowinsky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|